Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery

Completed

Conditions studied: Pain Management, Function, Minimally Invasive Total Knee Arthroplasty, Celecoxib

In brief

This study will evaluate the benefits of continuing celecoxib through six weeks of total knee arthroplasty recovery. This is a randomized, double blind study with a group of approximately 130 primary total knee patients. All patients will receive celecoxib throughout their hospitalization as per current minimally invasive total knee arthroplasty protocol. At the time of hospital discharge, participating patients will be randomly placed on either celecoxib 200mg twice a day or a placebo twice a day. This study will determine if the continued use of celecoxib for six weeks after total knee arthroplasty hospitalization will further decrease narcotic consumption, improve knee range of motion, improve ambulatory ability, and improve patient satisfaction over patients receiving celecoxib only during the acute hospitalization.

Key facts

Study ID

NCT00474773

Run by

St. Louis Joint Replacement Institute

People needed

107

Starts

2007-06-01

Expected to finish

2009-12-01

Last updated by the study team

2016-04-28

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• having undergone a minimally invasive total knee by select surgeon
• voluntarily enrolled
• independent community ambulators
• only patients being discharged directly home

You may not qualify if…

• celecoxib allergy or intolerence
• Renal insufficiency (defined as serum creatine level >1.5 mg/dL or BUN level >22mg/dL
• History of bleeding gastic or duodenal ulceration
• New York Heart Association Class III or IV Congestive Heart Failure
• Previous myocardial infarction or cerebralvascular event
• Severe inflammatory bowel disease
• Known coagulation abnormality or hepatic disease
• Chronic coumadin administration
• Refusal by primary or cardiac physician

Where it is running

• DePaul Health Center — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.